The world of cancer treatment is ever-evolving, and recent developments have brought a glimmer of hope for those battling non-small cell lung cancer (NSCLC). iTeos Therapeutics has unveiled promising results from a mid-stage clinical trial examining the efficacy of combining their drug,
The landscape of cell therapy manufacturing is on the brink of transformation as Cellares, an Integrated Development and Manufacturing Organization (IDMO), partners with Sony Corporation to integrate advanced cell analysis and sorting technologies into an already sophisticated manufacturing
The ongoing legal battle between MMJ BioPharma Cultivation and the Drug Enforcement Administration (DEA) exemplifies the hurdles faced by companies attempting to break into pharmaceutical-grade cannabis research. MMJ BioPharma has encountered significant bureaucratic delays, stalling their efforts
Recent advancements in cancer treatments have provided new hope for patients, with significant progress showcased in the biopharmaceutical industry. The interim results of ArriVent BioPharma, Inc.'s Phase 1b FURTHER trial for their drug firmonertinib have been particularly promising. This
The world of cell therapy manufacturing is on the verge of a significant transformation. The partnership between Cellares, a leader in automated cell therapy manufacturing, and Sony Corporation, a technological giant renowned for its advanced flow cytometry, promises to reshape this burgeoning
Sleep disorders are a growing public health concern, impacting millions of individuals worldwide. Addressing these disorders effectively has long been a challenge for pharmaceutical companies. Enter Centessa Pharmaceuticals, a London-based biotechnology company that has made headlines with its
